Remifentanil

This classification denotes an opioid receptor agonist and opioid with the molecular formula C20H28N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P10582JYYK, chemically known as 1-piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester but generally known as remifentanil, which bears US NIH Compound Identifier 60815. European Medicines Agency schedules Remifentanil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10272MIG. The term REMIFENTANIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). World Health Organization schedules remifentanil in its Anatomical Therapeutic Chemical (ATC) Classification. REMIFENTANIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule remifentanil under HS 29333999 and SITC 51574. As of Q4 2014, REMIFENTANIL remains the US FDA Preferred Term for this commodity. Remifentanil bears US NLM identifiers UMLS ID C0246631 and NCI Concept Code C66513. SMILES: O(C(=O)C1(N(C2CCCCC2)C(=O)CC)CCN(CC1)CCC(=O)OC)C.